{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:38:57Z","timestamp":1784385537675,"version":"3.55.0"},"reference-count":49,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alcohol-use disorders (AUD) pose a significant challenge for the United States (US) military. The US Department of Defense has strongly recommended several medications for use in the treatment of patients with diagnosed AUD. This study assessed the prescription of medications for active duty service members (ADSMs) diagnosed with AUD in the US Military Health System (MHS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Rates of prescription orders were retrospectively examined from 2010 to 2017 among ADSMs with an incident diagnosis of moderate-to-severe AUD. The rate of prescription orders was defined as the proportion of ADSMs with an ICD-9 or ICD-10 diagnosis code of alcohol dependence who received an order for acamprosate, disulfiram, naltrexone, and\/or topiramate at a military treatment facility in the year following their incident diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ADSMs receiving an order for at least one medication in the year following their incident AUD diagnosis increased from 8.8% in 2010 to 16.2% in 2017 (RR = 1.84, 95% CI, 1.76, 1.93). Oral naltrexone was ordered most frequently among this patient population, while injectable naltrexone, a medication option meant to ease and improve adherence, was ordered for a smaller proportion of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most ADSMs who might benefit from prescriptions for AUD are not receiving them as part of their treatment despite strong clinical evidence and Department of Defense policy support for their use among this cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2020.1809604","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T10:31:22Z","timestamp":1598956282000},"page":"638-645","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder"],"prefix":"10.1177","volume":"42","author":[{"given":"Zachary J.","family":"Peters","sequence":"first","affiliation":[{"name":"Psychological Health Center of Excellence, Defense Health Agency, Silver Spring, Maryland, USA"},{"name":"Salient CRGT, Inc., Fairfax, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa W.","family":"Kincaid","sequence":"additional","affiliation":[{"name":"Psychological Health Center of Excellence, Defense Health Agency, Silver Spring, Maryland, USA"},{"name":"Salient CRGT, Inc., Fairfax, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer G.","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Psychological Health Center of Excellence, Defense Health Agency, Silver Spring, Maryland, USA"},{"name":"Salient CRGT, Inc., Fairfax, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth F.","family":"Quah","sequence":"additional","affiliation":[{"name":"Psychological Health Center of Excellence, Defense Health Agency, Silver Spring, Maryland, USA"},{"name":"Salient CRGT, Inc., Fairfax, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Curry","sequence":"additional","affiliation":[{"name":"Psychological Health Center of Excellence, Defense Health Agency, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"World Health Organization. Global Status Report on Alcohol and Health 2018. Geneva: World Health Organization; 2018. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274603\/9789241565639-eng.pdf."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.05.031"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042262"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.5888\/pcd11.130293"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","unstructured":"Meadows SO Engel CC Collins RL . 2015 Department of Defense Health Related Behaviors Survey (HRBS). RAND report 1695. 2018. https:\/\/www.rand.org\/pubs\/research_reports\/RR1695.html.","DOI":"10.7249\/RR1695"},{"key":"e_1_3_4_7_2","volume-title":"2008 Department of Defense Survey of Health Related Behaviors among Active Duty Military Personnel","author":"Bray RM","year":"2009","unstructured":"Bray RM, , PembertonMR, , Hourani LL, . 2008 Department of Defense Survey of Health Related Behaviors among Active Duty Military Personnel. Research Triangle Park, NC: Research Triangle Institute; 2009."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-09-00132"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.01841.x"},{"key":"e_1_3_4_10_2","unstructured":"United States Department of Health and Human Assistant Secretary for Planning and Evaluation. Review of medication-assisted treatment guidelines and measures for opioid use and alcohol use. Washington D.C. 2015. https:\/\/aspe.hhs.gov\/report\/review-medication-assisted-treatment-guidelines-and-measures-opioid-and-alcohol-use\/e-summary-medication-assisted-treatment-quality-measures."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-03-9008"},{"issue":"10","key":"e_1_3_4_12_2","first-page":"9","article-title":"Alcohol-related diagnoses, active component, U.S. Armed Forces, 2001\u20132010","volume":"18","author":"Armed Forces Health Surveillance Branch","year":"2011","unstructured":"Armed Forces Health Surveillance Branch. Alcohol-related diagnoses, active component, U.S. Armed Forces, 2001\u20132010. MSMR. 2011;18(10):9\u201313.","journal-title":"MSMR"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED.172.9.950"},{"key":"e_1_3_4_14_2","unstructured":"Psychological Health Center of Excellence. Psychological Health by the Numbers: Mental Health Disorder Prevalence and Incidence among Active Duty Service Members 2005\u20132017. Falls Church VA: Defense Health Agency; 2019. https:\/\/www.pdhealth.mil\/research-analytics\/psychological-health-numbers\/mental-health-disorder-prevalence."},{"key":"e_1_3_4_15_2","unstructured":"Institute of Medicine. Substance Use Disorders in the U.S. Armed Forces. Washington DC: The National Academies Press. 2013."},{"key":"e_1_3_4_16_2","unstructured":"United States Department of Veterans Affairs & Department of Defense. VA\/DoD clinical practice guideline for the management of substance use disorders (Version 3.0). Washington D.C.: VA\/DOD Evidence Based Practice Guideline Work Group; 2015. https:\/\/www.healthquality.va.gov\/guidelines\/mh\/sud\/."},{"key":"e_1_3_4_17_2","unstructured":"Substance Abuse and Mental Health Services Administration and National Institute on Alcohol Abuse and Alcoholism. Medication for the Treatment of Alcohol Use Disorder: A Brief Guide. HHS Publication No. (SMA) 15-4907. Rockville MD: Substance Abuse and Mental Health Services Administration; 2015. https:\/\/store.samhsa.gov\/product\/Medication-for-the-Treatment-of-Alcohol-Use-Disorder-A-Brief-Guide\/SMA15-4907."},{"key":"e_1_3_4_18_2","unstructured":"Botticelli MP. Memorandum to heads of executive departments and agencies: Changing federal terminology regarding substance use and substance use disorders. Executive Office of the President Office of National Drug Control Policy; January 9 2017. https:\/\/www.whitehouse.gov\/sites\/whitehouse.gov\/files\/images\/Memo%20-%20Changing%20Federal%20Terminology%20Regrading%20Substance%20Use%20and%20Substance%20Use%20Disorders.pdf."},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3628"},{"issue":"12","key":"e_1_3_4_20_2","article-title":"Opioid antagonists for alcohol dependence","author":"R\u00f6sner S","year":"2010","unstructured":"R\u00f6sner S, , Hackl-Herrwerth A, , Leucht S, . Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867. Published 2010 Dec 8. https:\/\/doi.org\/10.1002\/14651858.CD001867.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1617"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12597"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-398338-1.00069-5"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13370-3"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.14.1641"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2016.1189477"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1028699"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2014.75.467"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3181d41ddb"},{"key":"e_1_3_4_30_2","unstructured":"United States Department of Veterans Affairs & Department of Defense. VA\/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (Version 2.0). Washington D.C.: VA\/DOD Evidence Based Practice Guideline Work Group; 2009. https:\/\/www.healthquality.va.gov\/guidelines\/MH\/sud\/sud_full_601f.pdf."},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1940-0640-8-12"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2010.61.4.392"},{"key":"e_1_3_4_33_2","unstructured":"Armed Forces Health Surveillance Branch. AFHSB surveillance case definitions: substance-related disorders. 2017. https:\/\/health.mil\/Military-Health-Topics\/Combat-Support\/Armed-Forces-Health-Surveillance-Branch\/Epidemiology-and-Analysis\/Surveillance-Case-Definitions."},{"key":"e_1_3_4_34_2","unstructured":"Armed Forces Health Surveillance Branch. AFHSB surveillance case definitions: epilepsy. 2017. https:\/\/health.mil\/Military-Health-Topics\/Combat-Support\/Armed-Forces-Health-Surveillance-Branch\/Epidemiology-and-Analysis\/Surveillance-Case-Definitions."},{"key":"e_1_3_4_35_2","unstructured":"Armed Forces Health Surveillance Branch. AFHSB surveillance case definitions: migraine headache. 2017. https:\/\/health.mil\/Military-Health-Topics\/Combat-Support\/Armed-Forces-Health-Surveillance-Branch\/Epidemiology-and-Analysis\/Surveillance-Case-Definitions."},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14183"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13601"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.03.023"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13772"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/35.6.537"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2010.71.460"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2019.00284"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1640833"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1362419"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0244-0"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2015.76.143"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0030949"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-016-0063-8"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-11-00421"},{"key":"e_1_3_4_50_2","unstructured":"Secretary of the Army. Army directive 2019\u201312 (policy for voluntary alcohol-related behavioral healthcare). 2019. https:\/\/armypubs.army.mil\/epubs\/DR_pubs\/DR_a\/pdf\/web\/ARN16186_AD2019-12_Web_Final.pdf."}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2020.1809604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2020.1809604","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2020.1809604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:30:54Z","timestamp":1780507854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2020.1809604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1080\/08897077.2020.1809604"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2020.1809604","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}